SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 70 filers reported holding SYNERON MEDICAL LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,399,000 | +16.7% | 335,570 | +73.4% | 0.00% | 0.0% |
| Q2 2015 | $2,056,000 | -27.3% | 193,558 | -15.3% | 0.00% | 0.0% |
| Q1 2015 | $2,830,000 | +32.7% | 228,558 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,132,000 | -6.9% | 228,558 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,290,000 | -51.4% | 228,558 | -50.0% | 0.00% | 0.0% |
| Q2 2014 | $4,716,000 | +65.7% | 457,116 | +100.0% | 0.00% | -50.0% |
| Q1 2014 | $2,846,000 | +1.2% | 228,558 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,812,000 | +42.7% | 228,558 | 0.0% | 0.00% | +100.0% |
| Q3 2013 | $1,970,000 | -0.9% | 228,558 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $1,988,000 | +69.9% | 228,558 | +99.8% | 0.00% | 0.0% |
| Q1 2013 | $1,170,000 | -50.1% | 114,403 | -50.0% | 0.00% | -50.0% |
| Q3 2012 | $2,345,000 | +100.4% | 228,806 | +100.0% | 0.00% | +100.0% |
| Q2 2012 | $1,170,000 | – | 114,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 706,107 | $5,931,000 | 5.46% |
| NORTH TIDE CAPITAL, LLC | 3,500,000 | $29,400,000 | 5.03% |
| Senvest Management, LLC | 3,777,775 | $31,733,000 | 2.26% |
| Kenmare Capital Partners, L.L.C. | 269,839 | $2,267,000 | 1.72% |
| Camber Capital Management LP | 2,347,593 | $19,720,000 | 1.03% |
| DALTON GREINER HARTMAN MAHER & CO | 1,785,826 | $15,001,000 | 0.88% |
| PERRITT CAPITAL MANAGEMENT INC | 425,170 | $3,571,000 | 0.87% |
| Profit Investment Management, LLC | 88,777 | $746,000 | 0.70% |
| DAFNA Capital Management LLC | 85,947 | $722,000 | 0.63% |
| Lapides Asset Management, LLC | 396,800 | $3,333,000 | 0.60% |